Details of the Drug

General Information of Drug (ID: DMFTKSI)

• Drug Name: KDT-3594

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]

• Cross-matching ID:
  DrugBank ID: DB17085
  TTD ID: D2ZA8S

References

• [1] ClinicalTrials.gov (NCT04867551) A Phase II Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease. U.S.National Institutes of Health.